Skip to main content
. 2014 Feb 12;14:40. doi: 10.1186/1471-2431-14-40

Table 3.

Course of developmental delay over the 2-year surveillance period in relation to various factors

Factors
 
DQ difference*
P
    Median Range  
Prenatal
 
 
 
 
Fecundation in vitro
yes
9.2
-4.0 to 23.0
0.687
 
no
10.0
-10 to 42.0
 
Drug exposure in pregnancy †
yes
8.5
-10 to 27.0
0.244
 
no
10.0
-5.0 to 42.0
 
Tobacco smoke exposure in pregnancy
yes
9
-10.0 to 35.0
0.340
 
no
10.0
-5.0 to 42.0
 
Multiple gestation
yes
9.0
-10.0 to 20.0
0.169
 
no
10.0
-5.0 to 42.0
 
Prematurity
yes
7.5
-10.0 to 18.0
0.022
 
no
10.0
-4.0 to 42.0
 
IUGR
yes
7.0
-10.0 to 15.0
0.006
 
no
10.0
0.0 to 42.0
 
Hypertensive disease of pregnancy ‡
yes
9.5
-10.0 to 38.0
0.904
 
no
10.0
-5.0 to 42.0
 
Hemorrhagic complications of pregnancy §
yes
9.0
-10.0 to 36.0
0.820
 
no
10.00
-5.0 to 42.0
 
Perinatal
 
 
 
 
Cesarean section
yes
10.0
-10.0 to 36.0
0.880
 
no
10.0
-5.0 to 42.0
 
Birth asphyxia
yes
9.0
-5.0 to 35.0
0.620
 
no
10.0
-10.0 to 42.0
 
Neonatal hypoxia ||
yes
8.0
-10.0 to 15.0
0.024
 
no
10.5
0.0 to 42.0
 
Neonatal infection
yes
9.0
-4.0 to 42.0
0.870
 
no
10.0
-10.0 to 35.0
 
Other
 
 
 
 
Low socio-economic status
yes
6.0
-10.0 to 10.0
<0.001
 
no
11.0
0.0 to 42.0
 
Adherence to recommendations and treatment
yes
12.0
0.0 to 42
<0.001
  no 5.0 -10.0 to 12  

*calculated as DQ(2-year visit)–DQ(initial visit).

Between-group differences are calculated with Mann–Whitney U test.

†exposure to alcohol and illicit drugs; ‡ preeclampsia, eclampsia; § placental abruption, placenta previa; || need for ventilatory support due to respiratory distress or severe apneas.

DQ indicates developmental quotient; IUGR intrauterine growth restriction.